• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲卒中组织(ESO)失语症康复指南。

European Stroke Organisation (ESO) guideline on aphasia rehabilitation.

作者信息

Brady Marian C, Mills Claire, Prag Øra Hege, Novaes Natalia, Becker Frank, Constantinidou Fofi, Flöel Agnes, Sunnerhagen Katharina S, Isaksen Jytte, Jagoe Caroline, Jesus Luis Mt, Marangolo Paola, Meinzer Marcus, van der Meulen Ineke, Campbell Pauline, Ho Leonard, Hussain Salman, Hilari Katerina

机构信息

Glasgow Caledonian University, Glasgow, UK.

Leeds Teaching Hospitals NHS Trust, Leeds, UK.

出版信息

Eur Stroke J. 2025 May 22:23969873241311025. doi: 10.1177/23969873241311025.

DOI:10.1177/23969873241311025
PMID:40401776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12098336/
Abstract

Evidence of effective aphasia rehabilitation is emerging, yet intervention and delivery varies widely. This European Stroke Organisation guideline adhered to the guideline development standard procedures and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. The resulting multi-disciplinary, evidence-based recommendations support the delivery of high-quality stroke-related aphasia rehabilitation. The working group identified 10 clinically relevant aphasia rehabilitation questions and rated outcomes' relevance and importance. Following systematic searching, independent reviewers screened title-abstracts and full-texts for randomised controlled trials of speech-language therapy (SLT) for stroke-related aphasia. Results were profiled using PRISMA. Risk-of-bias was evaluated using the Cochrane Risk-of-Bias 1 tool. We prioritised final-value data. Where possible we conducted meta-analyses (RevMan) using random effects and mean, standardised mean differences (functional communication, quality of life, aphasia severity, auditory comprehension and spoken language outcomes) or odds ratios (adverse events). Using GRADE, we judged quality of the evidence (high-to-very low) and ESO recommendation strength (very strong-to-very weak). Where evidence was insufficient to support recommendations, expert opinions were described. Based on low-quality evidence we recommend the provision of higher total SLT dose (⩾20 h) and suggest higher SLT intensity and frequency to improve outcomes in aphasia rehabilitation. Similarly, we suggest the provision of individually-tailored SLT and digital and group therapy delivery models. Very low-level evidence for transcranial direct current stimulation (tDCS) with SLT informed the expert consensus that such interventions should only be provided in the context of high-quality trials. Evidence-based clinical-research priorities to inform SLT aphasia rehabilitation intervention choice and delivery are highlighted.

摘要

有效的失语症康复证据正在不断涌现,但干预措施和实施方式差异很大。本欧洲卒中组织指南遵循了指南制定的标准程序以及推荐分级、评估、制定与评价(GRADE)方法。由此产生的多学科、基于证据的建议支持提供高质量的卒中相关性失语症康复服务。工作组确定了10个与临床相关的失语症康复问题,并对结果的相关性和重要性进行了评级。在系统检索之后,独立评审人员筛选了标题摘要和全文,以查找针对卒中相关性失语症的言语语言治疗(SLT)随机对照试验。结果使用PRISMA进行了描述。使用Cochrane偏倚风险1工具评估偏倚风险。我们优先考虑最终价值数据。在可能的情况下,我们使用随机效应以及均值、标准化均值差(功能性沟通、生活质量、失语症严重程度、听觉理解和口语结果)或比值比(不良事件)进行了荟萃分析(RevMan)。使用GRADE,我们判断了证据质量(高至极低)和欧洲卒中组织的推荐强度(极强至极弱)。在证据不足以支持推荐的情况下,描述了专家意见。基于低质量证据,我们建议提供更高的SLT总剂量(⩾20小时),并建议提高SLT强度和频率以改善失语症康复结果。同样,我们建议提供个性化的SLT以及数字和团体治疗实施模式。经颅直流电刺激(tDCS)联合SLT的极低水平证据使专家达成共识,即此类干预措施应仅在高质量试验的背景下提供。强调了为指导SLT失语症康复干预选择和实施而开展基于证据的临床研究重点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/e65b0ad0acc2/10.1177_23969873241311025-fig18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/9a25c6ee49be/10.1177_23969873241311025-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/d74565063e17/10.1177_23969873241311025-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/910f9796f766/10.1177_23969873241311025-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/ad43a31acf80/10.1177_23969873241311025-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/11a577019d94/10.1177_23969873241311025-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/1fc637f3a91c/10.1177_23969873241311025-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/f5b714655b49/10.1177_23969873241311025-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/35030f69c296/10.1177_23969873241311025-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/04cae35c6f1f/10.1177_23969873241311025-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/e9a168ebdc5e/10.1177_23969873241311025-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/887b343353d4/10.1177_23969873241311025-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/a2a937c5756a/10.1177_23969873241311025-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/fe993eb3860f/10.1177_23969873241311025-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/2d1991a693ac/10.1177_23969873241311025-fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/07794de4988d/10.1177_23969873241311025-fig15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/ee8da9640010/10.1177_23969873241311025-fig16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/aa3cb2fcdc1c/10.1177_23969873241311025-fig17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/e65b0ad0acc2/10.1177_23969873241311025-fig18.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/9a25c6ee49be/10.1177_23969873241311025-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/d74565063e17/10.1177_23969873241311025-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/910f9796f766/10.1177_23969873241311025-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/ad43a31acf80/10.1177_23969873241311025-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/11a577019d94/10.1177_23969873241311025-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/1fc637f3a91c/10.1177_23969873241311025-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/f5b714655b49/10.1177_23969873241311025-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/35030f69c296/10.1177_23969873241311025-fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/04cae35c6f1f/10.1177_23969873241311025-fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/e9a168ebdc5e/10.1177_23969873241311025-fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/887b343353d4/10.1177_23969873241311025-fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/a2a937c5756a/10.1177_23969873241311025-fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/fe993eb3860f/10.1177_23969873241311025-fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/2d1991a693ac/10.1177_23969873241311025-fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/07794de4988d/10.1177_23969873241311025-fig15.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/ee8da9640010/10.1177_23969873241311025-fig16.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/aa3cb2fcdc1c/10.1177_23969873241311025-fig17.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ba2/12098336/e65b0ad0acc2/10.1177_23969873241311025-fig18.jpg

相似文献

1
European Stroke Organisation (ESO) guideline on aphasia rehabilitation.欧洲卒中组织(ESO)失语症康复指南。
Eur Stroke J. 2025 May 22:23969873241311025. doi: 10.1177/23969873241311025.
2
Precision rehabilitation for aphasia by patient age, sex, aphasia severity, and time since stroke? A prespecified, systematic review-based, individual participant data, network, subgroup meta-analysis.按患者年龄、性别、失语症严重程度和卒中后时间对失语症进行精准康复?一项基于预设、系统评价的个体参与者数据、网络、亚组荟萃分析。
Int J Stroke. 2022 Dec;17(10):1067-1077. doi: 10.1177/17474930221097477. Epub 2022 May 18.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Speech and language therapy for aphasia following stroke.中风后失语症的言语和语言治疗
Cochrane Database Syst Rev. 2016 Jun 1;2016(6):CD000425. doi: 10.1002/14651858.CD000425.pub4.
5
6
European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage.欧洲卒中组织(ESO)和欧洲神经外科学会协会(EANS)关于自发性脑出血所致卒中的指南。
Eur Stroke J. 2025 May 22:23969873251340815. doi: 10.1177/23969873251340815.
7
Speech and language therapy for aphasia following stroke.中风后失语症的言语和语言治疗
Cochrane Database Syst Rev. 2012 May 16(5):CD000425. doi: 10.1002/14651858.CD000425.pub3.
8
Transcranial direct current stimulation (tDCS) for improving aphasia in adults with aphasia after stroke.经颅直流电刺激(tDCS)改善成人脑卒中后失语症
Cochrane Database Syst Rev. 2019 May 21;5(5):CD009760. doi: 10.1002/14651858.CD009760.pub4.
9
Dosage, Intensity, and Frequency of Language Therapy for Aphasia: A Systematic Review-Based, Individual Participant Data Network Meta-Analysis.失语症语言治疗的剂量、强度和频率:基于系统评价的个体参与者数据网络荟萃分析。
Stroke. 2022 Mar;53(3):956-967. doi: 10.1161/STROKEAHA.121.035216. Epub 2021 Dec 1.
10
Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT.计算机化言语和语言治疗或注意力控制联合常规护理用于长期卒中后失语症患者:大 CACTUS 三臂 RCT。
Health Technol Assess. 2020 Apr;24(19):1-176. doi: 10.3310/hta24190.

本文引用的文献

1
Transcranial direct stimulation over left inferior frontal gyrus improves language production and comprehension in post-stroke aphasia: A double-blind randomized controlled study.经颅直流电刺激左额下回改善脑卒后失语症患者的语言产出和理解:一项双盲随机对照研究。
Brain Lang. 2024 Oct;257:105459. doi: 10.1016/j.bandl.2024.105459. Epub 2024 Sep 5.
2
Success rates of intensive aphasia therapy: real-world data from 448 patients between 2003 and 2020.强化失语症治疗的成功率:2003 年至 2020 年间 448 例患者的真实世界数据。
J Neurol. 2024 Nov;271(11):7169-7183. doi: 10.1007/s00415-024-12429-7. Epub 2024 May 20.
3
Electric field simulation and appropriate electrode positioning for optimized transcranial direct current stimulation of stroke patients: an in Silico model.
电场模拟及优化脑卒中患者经颅直流电刺激的电极定位:一项计算机模型研究。
Sci Rep. 2024 Feb 3;14(1):2850. doi: 10.1038/s41598-024-52874-y.
4
Prevalence, Trajectory, and Predictors of Poststroke Pain: Retrospective Analysis of Pooled Clinical Trial Data Set.卒中后疼痛的患病率、病程及预测因素:汇总临床试验数据集的回顾性分析。
Stroke. 2023 Dec;54(12):3107-3116. doi: 10.1161/STROKEAHA.123.043355. Epub 2023 Nov 2.
5
Long-term effects of transcranial direct current stimulation (tDCS) combined with speech language therapy (SLT) on post-stroke aphasia patients: A systematic review and network meta-analysis of randomized controlled trials.经颅直流电刺激(tDCS)联合言语语言治疗(SLT)对脑卒中后失语症患者的长期影响:系统评价和随机对照试验的网络荟萃分析。
NeuroRehabilitation. 2023;53(3):285-296. doi: 10.3233/NRE-230099.
6
An updated systematic review of stroke clinical practice guidelines to inform aphasia management.更新的脑卒中临床实践指南系统评价,为失语症管理提供信息。
Int J Stroke. 2023 Oct;18(9):1029-1039. doi: 10.1177/17474930231161454. Epub 2023 Mar 9.
7
Rehabilitation Therapy Doses Are Low After Stroke and Predicted by Clinical Factors.中风后康复治疗剂量低,可由临床因素预测。
Stroke. 2023 Mar;54(3):831-839. doi: 10.1161/STROKEAHA.122.041098. Epub 2023 Feb 3.
8
A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization.一项代表世界卒中组织的全球卒中指南的系统评价和综合。
Int J Stroke. 2023 Jun;18(5):499-531. doi: 10.1177/17474930231156753. Epub 2023 Mar 1.
9
Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.测量失语症试验中的沟通情况作为核心结局指标:ROMAA-2 国际核心结局集开发会议的结果。
Int J Lang Commun Disord. 2023 Jul-Aug;58(4):1017-1028. doi: 10.1111/1460-6984.12840. Epub 2022 Dec 30.
10
Establishing reporting standards for participant characteristics in post-stroke aphasia research: An international e-Delphi exercise and consensus meeting.建立卒中后失语症研究中参与者特征报告标准:一项国际电子德尔菲法研究和共识会议。
Clin Rehabil. 2023 Feb;37(2):199-214. doi: 10.1177/02692155221131241. Epub 2022 Oct 16.